As of September 2026, 467 paid clinical trials are recruiting in Kansas City, Missouri. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Kansas City offers studies at sites including University of Kansas Cancer Center - North for conditions such as Heart Failure, Breast Cancer, Malignant Solid Neoplasm, Chronic Lymphocytic Leukemia. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Researchers run research studies in Kansas City, MO at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of Kansas Cancer Center - North | Anatomic Stage II Breast Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Recurrent Lung Non-Small Cell Carcinoma | 47 |
| Children's Mercy Hospital | Bronchopulmonary Dysplasia, Congenital Heart Disease (CHD), Membranous Nephropathy | 42 |
| Children's Mercy Hospitals and Clinics | Amblyopia, B Acute Lymphoblastic Leukemia, Malignant Solid Neoplasm | 40 |
| University of Kansas Cancer Center - Briarcliff | Anatomic Stage II Breast Cancer AJCC v8, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 | 35 |
| University Health Truman Medical Center | Anatomic Stage II Breast Cancer AJCC v8, Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma | 31 |
| Saint Luke's Hospital of Kansas City | Heart Failure, Breast Cancer, Acute Kidney Injury | 30 |
| Saint Luke's Cancer Institute | Breast Cancer, Breast Neoplasms, Metastatic Breast Cancer | 13 |
| Children's Mercy Kansas City | ALL, Childhood, Behavior, Health, Bronchiolitis Acute | 12 |
| Kansas City Veterans Affairs Medical Center | Chronic Lymphocytic Leukemia, RISS Stage I Plasma Cell Myeloma, RISS Stage II Plasma Cell Myeloma | 12 |
| Research Medical Center | Atrial Fibrillation, Stroke, Anatomic Stage II Breast Cancer AJCC v8 | 12 |
| Children's Mercy | Acute Brain Injury, Angelman Syndrome, Autism | 7 |
| Research Medical Center Clinic | Atrial Fibrillation, Stroke, Aortic Stenosis | 7 |
| St. Luke's Hospital of Kansas City | Amyloid Cardiomyopathy, Amyloidosis, Aortic Stenosis | 7 |
| Kansas City VA Medical Center, Kansas City, MO | Adult Growth Hormone Deficiency, Atherosclerosis, BARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2 | 6 |
| Kansas City VA Medical Center | Heart Failure, Cardiovascular Diseases, Cognitive Impairment, Mild | 6 |
| MidAmerica Cancer Care | Advanced Melanoma, Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms | 5 |
| The Children's Mercy Hospital | Alagille Syndrome, Congenital Heart Disease (CHD), Cystic Fibrosis | 5 |
| University Health | Hypovolemia, Overweight and Obesity, PreDiabetes | 5 |
| Clinical Trial Site | Breast Cancer, ER Positive Breast Cancer, HER2 Negative Breast Carcinoma | 4 |
| Alliance for Multispecialty Research - Kansas City | Obesity, Overweight, Atherosclerotic Cardiovascular Disease | 4 |
| Children's Mercy Research Institute | Anorexia Nervosa, Atypical, Binge Eating, Bulimia Nervosa | 4 |
| GSK Investigational Site | HIV Infections, Non-alcoholic Fatty Liver Disease, Metabolic Dysfunction-Associated Steatohepatitis | 4 |
| Kansas City Research Institute | Chronic Idiopathic Constipation (CIC), Liver Fibrosis, MASH - Metabolic Dysfunction-Associated Steatohepatitis | 4 |
| Saint Luke's Hospital | Intra-uterine Device Placement, Mitral Valve Prolapse, Mitral Valve Regurgitation (Degenerative or Functional) | 4 |
| Saint Luke's Mid America Heart Institute | Cardiovascular Diseases, Heart Failure, Heart Valve Diseases | 4 |
Recruiting trials in Kansas City grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
There are approximately 467 recruiting clinical trials in Kansas City, Missouri listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Kansas City compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Kansas City include Heart Failure (17), Breast Cancer (13), Malignant Solid Neoplasm (7), Chronic Lymphocytic Leukemia (6), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Kansas City on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Kansas City include University of Kansas Cancer Center - North, Children's Mercy Hospital, Children's Mercy Hospitals and Clinics, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Kansas City are Cancer & tumors (143), Cardiovascular (60), Diabetes & metabolic (31). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.